Breaking News, Financial News

Financial Report: Sanofi 3Q

Product sales up for the first time in five quarters

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi 3Q Revenues: €8.4 billion (-7%) 3Q Earnings: €1.8 billion (-19%) YTD Revenues: €24.5 billion (-7%) YTD Earnings: €4.9 billion (-26%) Comments: Pharmaceutical sales were €6.7 million in the quarter, up 3%.Sales lost to generic competition on key legacy products in the U.S. and EU were €191 million. Diabetes sales were up 20% to €1.7 million with Lantus sales of €1.5 million (+21%). Vaccines sales were €1.3 billion (-7%) impacted by supply limitations of Pentaceland Adacel in the U.S. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters